Wheeler Paul R, Coldham Nicholas G, Keating Lisa, Gordon Stephen V, Wooff Esen E, Parish Tanya, Hewinson R Glyn
Tuberculosis Research Group, Veterinary Laboratories Agency (Weybridge), New Haw, Addlestone KT15 3NB, United Kingdom.
J Biol Chem. 2005 Mar 4;280(9):8069-78. doi: 10.1074/jbc.M412540200. Epub 2004 Dec 2.
Methionine can be used as the sole sulfur source by the Mycobacterium tuberculosis complex although it is not obvious from examination of the genome annotation how these bacteria utilize methionine. Given that genome annotation is a largely predictive process, key challenges are to validate these predictions and to fill in gaps for known functions for which genes have not been annotated. We have addressed these issues by functional analysis of methionine metabolism. Transport, followed by metabolism of (35)S methionine into the cysteine adduct mycothiol, demonstrated the conversion of exogenous methionine to cysteine. Mutational analysis and cloning of the Rv1079 gene showed it to encode the key enzyme required for this conversion, cystathionine gamma-lyase (CGL). Rv1079, annotated metB, was predicted to encode cystathionine gamma-synthase (CGS), but demonstration of a gamma-elimination reaction with cystathionine as well as the gamma-replacement reaction yielding cystathionine showed it encodes a bifunctional CGL/CGS enzyme. Consistent with this, a Rv1079 mutant could not incorporate sulfur from methionine into cysteine, while a cysA mutant lacking sulfate transport and a methionine auxotroph was hypersensitive to the CGL inhibitor propargylglycine. Thus, reverse transsulfuration alone, without any sulfur recycling reactions, allows M. tuberculosis to use methionine as the sole sulfur source. Intracellular cysteine was undetectable so only the CGL reaction occurs in intact mycobacteria. Cysteine desulfhydrase, an activity we showed to be separable from CGL/CGS, may have a role in removing excess cysteine and could explain the ability of M. tuberculosis to recycle sulfur from cysteine, but not methionine.
结核分枝杆菌复合体可以将甲硫氨酸用作唯一的硫源,尽管从基因组注释中并不明显看出这些细菌如何利用甲硫氨酸。鉴于基因组注释在很大程度上是一个预测过程,关键挑战在于验证这些预测,并填补尚未注释基因的已知功能的空白。我们通过对甲硫氨酸代谢的功能分析解决了这些问题。将(35)S甲硫氨酸转运并代谢为半胱氨酸加合物分枝硫醇,证明了外源性甲硫氨酸向半胱氨酸的转化。Rv1079基因的突变分析和克隆表明它编码这种转化所需的关键酶胱硫醚γ-裂合酶(CGL)。注释为metB的Rv1079被预测编码胱硫醚γ-合酶(CGS),但以胱硫醚为底物的γ-消除反应以及产生胱硫醚的γ-置换反应表明它编码一种双功能的CGL/CGS酶。与此一致的是,Rv1079突变体不能将甲硫氨酸中的硫掺入半胱氨酸中,而缺乏硫酸盐转运的cysA突变体和甲硫氨酸营养缺陷型对CGL抑制剂炔丙基甘氨酸高度敏感。因此,仅逆向转硫作用,无需任何硫循环反应,就使结核分枝杆菌能够将甲硫氨酸用作唯一的硫源。完整的分枝杆菌中未检测到细胞内半胱氨酸,因此只有CGL反应发生。我们发现半胱氨酸脱硫酶的活性可与CGL/CGS分离,它可能在去除过量半胱氨酸方面发挥作用,并可以解释结核分枝杆菌从半胱氨酸而非甲硫氨酸中回收硫的能力。